BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19861161)

  • 1. c-Cbl acts as a mediator of Src-induced activation of the PI3K-Akt signal transduction pathway during TRAIL treatment.
    Song JJ; Kim JH; Sun BK; Alcala MA; Bartlett DL; Lee YJ
    Cell Signal; 2010 Mar; 22(3):377-85. PubMed ID: 19861161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAIL/MEKK4/p38/HSP27/Akt survival network is biphasically modulated by the Src/CIN85/c-Cbl complex.
    Kim J; Kang D; Sun BK; Kim JH; Song JJ
    Cell Signal; 2013 Jan; 25(1):372-9. PubMed ID: 23085457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Cbl-mediated degradation of TRAIL receptors is responsible for the development of the early phase of TRAIL resistance.
    Song JJ; Szczepanski MJ; Kim SY; Kim JH; An JY; Kwon YT; Alcala MA; Bartlett DL; Lee YJ
    Cell Signal; 2010 Mar; 22(3):553-63. PubMed ID: 19932172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRAIL-induced caspase/p38 activation is responsible for the increased catalytic and invasive activities of Akt.
    Sun BK; Kim JH; Nguyen HN; Kim SY; Oh S; Lee YJ; Song JJ
    Int J Oncol; 2011 Jan; 38(1):249-56. PubMed ID: 21109947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Src is required for tropomyosin receptor kinase C (TrkC)-induced activation of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway.
    Jin W; Yun C; Jeong J; Park Y; Lee HD; Kim SJ
    J Biol Chem; 2008 Jan; 283(3):1391-1400. PubMed ID: 17991742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF-alpha induces MMP-9 expression via activation of Src/EGFR, PDGFR/PI3K/Akt cascade and promotion of NF-kappaB/p300 binding in human tracheal smooth muscle cells.
    Lee CW; Lin CC; Lin WN; Liang KC; Luo SF; Wu CB; Wang SW; Yang CM
    Am J Physiol Lung Cell Mol Physiol; 2007 Mar; 292(3):L799-812. PubMed ID: 17158602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latent membrane protein 1 mediates the resistance of nasopharyngeal carcinoma cells to TRAIL-induced apoptosis by activation of the PI3K/Akt signaling pathway.
    Li SS; Yang S; Wang S; Yang XM; Tang QL; Wang SH
    Oncol Rep; 2011 Dec; 26(6):1573-9. PubMed ID: 21850380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Src family kinases blocks epidermal growth factor (EGF)-induced activation of Akt, phosphorylation of c-Cbl, and ubiquitination of the EGF receptor.
    Kassenbrock CK; Hunter S; Garl P; Johnson GL; Anderson SM
    J Biol Chem; 2002 Jul; 277(28):24967-75. PubMed ID: 11994282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted RNA interference of PI3K pathway components sensitizes colon cancer cells to TNF-related apoptosis-inducing ligand (TRAIL).
    Rychahou PG; Murillo CA; Evers BM
    Surgery; 2005 Aug; 138(2):391-7. PubMed ID: 16153452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of cbl family of ubiquitin ligases in gastric cancer exosome-induced apoptosis of Jurkat T cells.
    Qu JL; Qu XJ; Qu JL; Qu XJ; Zhao MF; Teng YE; Zhang Y; Hou KZ; Jiang YH; Yang XH; Liu YP
    Acta Oncol; 2009; 48(8):1173-80. PubMed ID: 19863226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cbl negatively regulates erythropoietin-induced growth and survival signaling through the proteasomal degradation of Src kinase.
    Shintani T; Ohara-Waki F; Kitanaka A; Tanaka T; Kubota Y
    Blood Cells Mol Dis; 2014 Dec; 53(4):211-8. PubMed ID: 25084697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HSP27 phosphorylation modulates TRAIL-induced activation of Src-Akt/ERK signaling through interaction with β-arrestin2.
    Qi S; Xin Y; Qi Z; Xu Y; Diao Y; Lan L; Luo L; Yin Z
    Cell Signal; 2014 Mar; 26(3):594-602. PubMed ID: 24308965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin ligase c-Cbl is involved in tamoxifen-induced apoptosis of MCF-7 cells by downregulating the survival signals.
    Yan SC; Liu YP; Zhang LY; Qu JL; Xu L; Liu J; Zhang Y; Hou KZ; Teng YE; Qu XJ
    Acta Oncol; 2011 Jun; 50(5):693-9. PubMed ID: 21175263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The E3 Ubiquitin Ligase c-Cbl Inhibits Microglia-Mediated CNS Inflammation by Regulating PI3K/Akt/NF-κB Pathway.
    Dong L; Li YZ; An HT; Wang YL; Chen SH; Qian YJ; Wang K; Zhen JL; Fan Z; Gong XL; Zheng Y; Wang XM
    CNS Neurosci Ther; 2016 Aug; 22(8):661-9. PubMed ID: 27156691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of FoxO-dependent c-FLIP expression mediates TRAIL-induced apoptosis in activated hepatic stellate cells.
    Park SJ; Sohn HY; Yoon J; Park SI
    Cell Signal; 2009 Oct; 21(10):1495-503. PubMed ID: 19470406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juvenile myelomonocytic leukaemia-associated mutation in Cbl promotes resistance to apoptosis via the Lyn-PI3K/AKT pathway.
    Bunda S; Qin K; Kommaraju K; Heir P; Ohh M
    Oncogene; 2015 Feb; 34(6):789-97. PubMed ID: 24469048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential response of neuroblastoma cells to TRAIL is independent of PI3K/AKT.
    Efron PA; Chen MK; Iyengar M; Dai W; Nagaram A; Beierle EA
    J Pediatr Surg; 2006 Jun; 41(6):1072-80. PubMed ID: 16769337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Epstein-Barr virus/C3d receptor (gp140, CR2, CD21) on human B lymphoma cell surface triggers Cbl tyrosine phosphorylation, its association with p85 subunit, Crk-L and Syk and its dissociation with Vav.
    Lottin-Divoux S; Jean D; Le Romancer M; Frade R
    Cell Signal; 2006 Aug; 18(8):1219-25. PubMed ID: 16289966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DR5-Cbl-b/c-Cbl-TRAF2 complex inhibits TRAIL-induced apoptosis by promoting TRAF2-mediated polyubiquitination of caspase-8 in gastric cancer cells.
    Xu L; Zhang Y; Qu X; Che X; Guo T; Li C; Ma R; Fan Y; Ma Y; Hou K; Li D; Hu X; Liu B; Yu R; Yan H; Gong J; Liu Y
    Mol Oncol; 2017 Dec; 11(12):1733-1751. PubMed ID: 28972304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway.
    Chen KF; Yeh PY; Hsu C; Hsu CH; Lu YS; Hsieh HP; Chen PJ; Cheng AL
    J Biol Chem; 2009 Apr; 284(17):11121-33. PubMed ID: 19261616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.